[Afternoon Session of the Second Day of the 2026 National Talks: Representatives from Merck, AstraZeneca, Roche, Innovent Biologics, Changchun Kinsey and other companies entered the venue one after another] September 6th, at around 13:00 today, the afternoon session of the 2026 National Basic Medical Insurance Drug List Negotiation Bidding and Commercial Insurance Innovative Drug List Price Negotiation officially opened. Reporters observed at the scene that negotiators from Merck, AstraZeneca, Roche, Sanofi, Innovent Biologics, Suzhou Shengdi, Beijing Northland, Hengrui Pharmaceuticals, Lepu Biotech and other companies entered the venue. There were about 20 negotiating companies. Compared with yesterday and this morning, there were significantly more people from foreign companies. (Reporters Lu Afeng and Yu Miao)